bpc-157 not approved for human use fda statement BPC-157's Review Raises Questions About Its Origins | American Peptide Society posted on the topic BPC-157: What you need to
Description
Tirzepatide doses are roughly 2 to 6 times larger than semaglutide doses for equivalent clinical effect
When considering BPC 157, it is critical to consult with a healthcare provider to ensure its appropriateness for individual needs

Specifically, age and FFM together accounted for 72% of the individual variation in AER

Enhances muscle recovery

That is a meaningful fraction of a dose

launch in 1997